Tony T Kalajian - Net Worth and Insider Trading
Tony T Kalajian Net Worth
The estimated net worth of Tony T Kalajian is at least $2,123 dollars as of 2025-07-17. Tony T Kalajian is the Sr.VP/Chief Accounting Officer of Insight Molecular Diagnostics Inc and owns about 750 shares of Insight Molecular Diagnostics Inc (IMDX) stock worth over $2,123. Details can be seen in Tony T Kalajian's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Tony T Kalajian has not made any transactions after 2020-08-03 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

Transaction Summary of Tony T Kalajian
Tony T Kalajian Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Tony T Kalajian owns 2 companies in total, including Insight Molecular Diagnostics Inc (IMDX) , and First Light Acquisition Group Inc (FLAG) .
Click here to see the complete history of Tony T Kalajian’s form 4 insider trades.
Insider Ownership Summary of Tony T Kalajian
Ticker | Company | Transaction Date | Type of Owner |
---|---|---|---|
IMDX | Insight Molecular Diagnostics Inc | 2020-08-03 | SVP-Chief Accounting Officer |
FLAG | First Light Acquisition Group Inc | 2023-09-12 | Chief Acctg Officer & Int. CFO |
Tony T Kalajian Latest Holdings Summary
Tony T Kalajian currently owns a total of 1 stock. Tony T Kalajian owns 750 shares of Insight Molecular Diagnostics Inc (IMDX) as of August 3, 2020, with a value of $2,123.
Latest Holdings of Tony T Kalajian
Ticker | Company | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
IMDX | Insight Molecular Diagnostics Inc | 2020-08-03 | 750 | 2.83 | 2,123 |
Holding Weightings of Tony T Kalajian
Tony T Kalajian Form 4 Trading Tracker
According to the SEC Form 4 filings, Tony T Kalajian has made a total of 1 transactions in Insight Molecular Diagnostics Inc (IMDX) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Insight Molecular Diagnostics Inc is the acquisition of 250 shares on August 3, 2020, which cost Tony T Kalajian around $6,550.
Insider Trading History of Tony T Kalajian
- 1
Tony T Kalajian Trading Performance
GuruFocus tracks the stock performance after each of Tony T Kalajian's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Tony T Kalajian is 5.41%. GuruFocus also compares Tony T Kalajian's trading performance to market benchmark return within the same time period. The performance of stocks bought by Tony T Kalajian within 3 months outperforms 1 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Tony T Kalajian's insider trading performs compared to the benchmark.
Performance of Tony T Kalajian
Tony T Kalajian Ownership Network
Ownership Network List of Tony T Kalajian
Ownership Network Relation of Tony T Kalajian

Tony T Kalajian Owned Company Details
What does Insight Molecular Diagnostics Inc do?
Who are the key executives at Insight Molecular Diagnostics Inc?
Tony T Kalajian is the SVP-Chief Accounting Officer of Insight Molecular Diagnostics Inc. Other key executives at Insight Molecular Diagnostics Inc include 10 percent owner Broadwood Partners Lp , Interim CEO Josh Riggs , and other: Former Director John Peter Gutfreund .
Insight Molecular Diagnostics Inc (IMDX) Insider Trades Summary
Over the past 18 months, Tony T Kalajian made no insider transaction in Insight Molecular Diagnostics Inc (IMDX). Other recent insider transactions involving Insight Molecular Diagnostics Inc (IMDX) include a net purchase of 1,188,987 shares made by Patrick W Smith , a net purchase of 8,901,034 shares made by Broadwood Partners Lp , and a net purchase of 151,231 shares made by .
In summary, during the past 3 months, insiders sold 0 shares of Insight Molecular Diagnostics Inc (IMDX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Insight Molecular Diagnostics Inc (IMDX) were sold and 10,291,040 shares were bought by its insiders, resulting in a net purchase of 10,291,040 shares.
Insight Molecular Diagnostics Inc (IMDX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Insight Molecular Diagnostics Inc Insider Transactions
Tony T Kalajian Mailing Address
Above is the net worth, insider trading, and ownership report for Tony T Kalajian. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Tony T Kalajian's mailing address is: Alameda Ca 94501.